SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001213900-24-016214
Filing Date
2024-02-22
Accepted
2024-02-22 17:21:51
Documents
14
Period of Report
2023-12-11
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FORM 8-K ea0200561-8ka1_aditxtinc.htm   iXBRL 8-K/A 28911
  Complete submission text file 0001213900-24-016214.txt   206951

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE adtx-20231211.xsd EX-101.SCH 3009
3 XBRL LABEL FILE adtx-20231211_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE adtx-20231211_pre.xml EX-101.PRE 22355
15 EXTRACTED XBRL INSTANCE DOCUMENT ea0200561-8ka1_aditxtinc_htm.xml XML 4394
Mailing Address 737 N. FIFTH STREET, SUITE 200 RICHMOND VA 23219
Business Address 737 N. FIFTH STREET, SUITE 200 RICHMOND VA 23219 909-488-0844
Aditxt, Inc. (Filer) CIK: 0001726711 (see all company filings)

IRS No.: 823204328 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-39336 | Film No.: 24666190
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)